Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Bertrand

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Obstetrics and Gynecology|November 13, 2025
Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy: Analysis From the 2024-2025 Immunization Campaign in FranceAmélie Gabet, Marion Bertrand, Marie-Joëlle Jabagi, et al.
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|September 26, 2023
Bone-anchored prostheses for lower limb amputation in a French cohort with 1-15 years of follow-up: implant survival rates, mechanical complications, and reported outcomesClara Thouvenin, Marion Bertrand-Marchand, Rémi Klotz, et al.
JAMA|January 25, 2018
Association of Hysteroscopic vs Laparoscopic Sterilization With Procedural, Gynecological, and Medical OutcomesKim Bouillon, Marion Bertrand, Georges Bader, et al.
Jac-Antimicrobial Resistance|August 18, 2025
Use of oral fluoroquinolones in France between 2014 and 2023: a nationwide drug utilization studyDaniele Saade, Marie-Joelle Jabagi, Marion Bertrand, et al.
Tissue Engineering|November 25, 2003
Engineering of a dermal equivalent: seeding and culturing fibroblasts in PEGT/PBT copolymer scaffoldsHong-Jun Wang, Marion Bertrand-de Haas, Clemens A van Blitterswijk, et al.
Therapie|May 22, 2026
Indication-related misuse of oral fluoroquinolones in adults by general practitioners in FranceLisa Dilange, Karima Hider-Mlynarz, Daniele Saade, et al.
BMJ (Clinical Research Ed.)|May 21, 2015
Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort studyAnnick Alpérovitch, Tobias Kurth, Marion Bertrand, et al.
BMC Geriatrics|July 25, 2009
Inappropriate medication use and risk of falls--a prospective study in a large community-dwelling elderly cohortSarah Berdot, Marion Bertrand, Jean-François Dartigues, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 10, 2025
Use of Semaglutide (Wegovy) in Adults in France: A Nationwide Drug Utilization StudyNadia Haddy, Hugo Jourdain, David Desplas, et al.
Presse Medicale (Paris, France : 1983)|April 23, 2013
[Use of drug reimbursement as markers of disease for epidemiological and cost analysis: The case of severe epilepsy in France]Francis Fagnani, Hervé Vespignani, Odile Kusnik-Joinville, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Obstetrics and Gynecology|November 13, 2025
Maternal and Neonatal Outcomes After Respiratory Syncytial Virus Prefusion F Protein Vaccination During Pregnancy: Analysis From the 2024-2025 Immunization Campaign in FranceAmélie Gabet, Marion Bertrand, Marie-Joëlle Jabagi, et al.
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|September 26, 2023
Bone-anchored prostheses for lower limb amputation in a French cohort with 1-15 years of follow-up: implant survival rates, mechanical complications, and reported outcomesClara Thouvenin, Marion Bertrand-Marchand, Rémi Klotz, et al.
JAMA|January 25, 2018
Association of Hysteroscopic vs Laparoscopic Sterilization With Procedural, Gynecological, and Medical OutcomesKim Bouillon, Marion Bertrand, Georges Bader, et al.
Jac-Antimicrobial Resistance|August 18, 2025
Use of oral fluoroquinolones in France between 2014 and 2023: a nationwide drug utilization studyDaniele Saade, Marie-Joelle Jabagi, Marion Bertrand, et al.
Tissue Engineering|November 25, 2003
Engineering of a dermal equivalent: seeding and culturing fibroblasts in PEGT/PBT copolymer scaffoldsHong-Jun Wang, Marion Bertrand-de Haas, Clemens A van Blitterswijk, et al.
Therapie|May 22, 2026
Indication-related misuse of oral fluoroquinolones in adults by general practitioners in FranceLisa Dilange, Karima Hider-Mlynarz, Daniele Saade, et al.
BMJ (Clinical Research Ed.)|May 21, 2015
Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort studyAnnick Alpérovitch, Tobias Kurth, Marion Bertrand, et al.
BMC Geriatrics|July 25, 2009
Inappropriate medication use and risk of falls--a prospective study in a large community-dwelling elderly cohortSarah Berdot, Marion Bertrand, Jean-François Dartigues, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 10, 2025
Use of Semaglutide (Wegovy) in Adults in France: A Nationwide Drug Utilization StudyNadia Haddy, Hugo Jourdain, David Desplas, et al.
Presse Medicale (Paris, France : 1983)|April 23, 2013
[Use of drug reimbursement as markers of disease for epidemiological and cost analysis: The case of severe epilepsy in France]Francis Fagnani, Hervé Vespignani, Odile Kusnik-Joinville, et al.
Pageof 5